DNA hypermethylation of tumor suppressor genes has been frequently observed in cancer patients, and therefore, may provide a valuable biomarker for cancer prevention and treatment. DNA hypermethylation may also provide an important mechanism in cancer progression. Lung cancer is strongly associated with exposure to environmental carcinogens, especially tobacco smoke. DNA damage generated by tobacco smoke is believed to play an important role in lung cancer development. XPC is a DNA damage recognition protein required for DNA repair and other DNA damage responses and attenuated XPC protein levels have been detected in many lung cancer patients. We studied the role of XPC protein deficiency in tobacco smoke-caused DNA hypermethylation of important tumor suppressor genes. Using both normal human fibroblasts (NF) and XPC-deficient hu man fibroblasts (XPC), our DNA methylation studies demonstrated that the XPC deficiency caused elevated levels of DNA hypermethylation in both Brca1 and Mlh1 tumor suppressor genes following exposure to tobacco smoke condensate (TSC). The results of our ChIP studies revealed that the XPC deficiency led to an increased binding of DNA methyltransferase 3A (DNMT3A) at the promoter region CpG island-containing sequences of these genes under the TSC treatment; however, this increase was partially diminished with prior treatment with caffeine. The results of our immuno-precipitation (IP) studies demonstrated a protein-protein interaction of the ATR with DNMT3A. Our western blots revealed that the XPC deficiency caused an increase in TSC-induced ATR phosphorylation at serine 428, an indicator of ATR activation. All these results suggest that XPC deficiency causes an accelerated DNA hypermethylation in important tumor suppressor genes under tobacco smoke exposure and activation of the ATR signaling pathway is involved in this DNA hypermethylation process.
INTRODUCTION
DNA hypermethylations of tumor suppressors and other cancer-related genes are frequently observed in cancer patients [1] [2] [3] [4] [5] , and therefore, may provide a valuable biomarker for cancer diagnosis and treatment. In addition, DNA hypermethylation may also provide an important mechanism in cancer progression. Understanding the mechanism of DNA hypermethylation, therefore, would have important implications in cancer prevention and treatment.
Lung cancer is one of the most common malignancies and the leading cause of cancer-related fatalities [6] . Lung cancer is strongly associated with exposure to environmental factors, especially tobacco smoking [6] . The molecular mechanism through which tobacco smoking causes lung cancer to develop is not fully understood. It is believed that DNA damage generated by carcinogens in the tobacco smoke and/or their metabolites plays an important role in lung cancer development. In addition, hypermethylation of important tumor suppressor genes also is frequently observed in lung cancer patients [7, 8] , suggesting a possible role of DNA hypermethylation in lung cancer progression.
Nucleotide excision repair (NER) is the major DNA repair pathway to repair DNA damage generated by environmental carcinogens, including tobacco smoke [9, 10] . The NER pathway can be further categorized into the transcription-coupled NER (TCR) and global-genome NER (GGR) sub-pathways [9, 11] . In TCR the arrested transcription events initiate the NER process [12, 13] , whereas in GGR the DNA damage recognition of the XPC-HR23B protein complex initiates the NER process [14, 15] . The DNA damage recognition signal further recruits other NER components, including XPA, RPA, TFIIH, XPG, XPF-ERCC1, to the damage site [9] . The dual-incision made by XPG and XPF-ERCC1 generates a 30 -33 nt single-stranded DNA gap [9, 14] . The DNA polymerases (δ or ε) fill the gap and the DNA ligase seals the gap to complete the NER process [9] .
In addition to its function in DNA repair, the XPC protein also plays an important role in other DNA damage responses, including cell cycle arrest and apoptosis [16] [17] [18] . The presence of a functional XPC protein, therefore, is essential in determining the fate of the damaged cells, either restoring the disrupted cellular functions through DNA repair or eliminating the severely damaged cells through apoptosis.
XPC protein attenuation and deficiency have been associated with many types of cancer. It is well known for the high risk in developing many types of cancer, especially skin cancer, in the XPC patients [10] ; recent clinical studies reveal greatly attenuated levels of XPC protein in a majority of lung and bladder cancer patients [19] [20] [21] . In addition, animal studies also reveal high predisposition towards skin and lung cancer when the XPC-knockout mice (XPC −/− ) are exposed to chemical carcinogen acetyl-amino-fluorene [22, 23] . All these results suggest that XPC protein attenuation and deficiency play an important role in cancer development, especially for those cancers associated with environmental factors such as lung and bladder cancer.
The mechanism through which XPC protein attenuation and deficiency cause cancer to develop is not known. Considering that both XPC protein attenuation and DNA hypermethylation of important tumor suppressor genes are frequently observed in cancer patients [19] [20] [21] , it is possible that hypermethylation of tumor suppressor genes may be an important mechanism for XPC protein attenuation and deficiency in causing cancer to develop. However, no studies have been done in determining the role of XPC protein attenuation and deficiency in hypermethylation of tumor suppressor genes and the involving mechanism.
In this work, we determined the role of XPC protein 
MATERIALS AND METHODS

Cell Lines and Oligonucleotides
The GM00043, GM03021, and GM16684 human fibroblasts were purchased from the Coriell Institute for Medical Research (Camden, NJ) and used in our previous studies [16] [17] [18] . The GM00043 are primary human fibroblasts derived from a normal individual (NF) and are proficient in nucleotide excision repair (NER) pathway. The GM03021 are primary human fibroblasts derived from a group G of xeroderma pigmentosum (XPG) patient and defective in XPG protein. 
Preparation of Tobacco Smoke Condensate (TSC)
The 2R4 Reference cigarette was purchased from the University of Kentucky College of Agriculture Reference Cigarette Program (Lexington, KY). The cigarettes were smoked on a standard smoking machine, taking 35-ml puffs of 2-sec duration once per min. The smoke was condensed in a trap cooled with liquid air. The collected material was dried onto filter paper, weighed, and dissolved in dimethylsulfoxide (DMSO) at 25 mg/ml. These values represent the equivalent of 10 cigarettes' worth of condensate per ml.
TSC Treatment and DNA/RNA Preparation
Cells were seeded in T-75 flask and grown to 40% confluence. The cells were treated with TSC at a concentration of 25 μg/ml by adding the TSC directly into the culture medium. For the Chromatin immuno-precipitation (ChIP) studies, cells were cultured in the TSC-containing medium for 48 hours. For the DNA methylation study, cells were maintained in the TSC-containing medium for up to two months with passage once every week. For the western blot study, cells were treated with TSC for 24 hours. Total RNA was isolated from cells using an RNeasy Mini kit (Qiagen, Valencia, CA). Genomic DNA was isolated from cells using a DNeasy Blood & Tissue Kit (Qiagen).
Methylated DNA Enrichment and Quantitation
The methylated DNA enrichment was done using a Methylminer Methylated DNA Enrichment system (Invitrogen, Carlsbad, CA). Genomic DNA was first digested with both BbvI and DpnI restriction enzymes to release the 373 bp, 390 bp, and 413 bp CpG island-containing DNA fragments from the promoter regions of the Brca1, Mlh1, and Xpc genes respectively. The methylated DNA fragments were then enriched from each DNA sample (1 μg total DNA) using a protocol recommended by the manufacturer and dissolved into 50 μl·dH 2 O. The methylation-enriched DNA samples were quantified using a quantitative PCR (qPCR) protocol to determine the DNA levels of the Brca1, Mlh1, and Xpc promoter region CpG island DNA sequences in each DNA sample. The qPCR was done at the following conditions: 2 μl DNA sample was mixed with 10 μl Power Sybr green master mix (Applied Biosystems) in a total volume of 20 μl containing 2 μM of each primer for a desired target genes. The reaction was set as triplicate for each DNA sample in a 96-well plate. The plate was placed in a StepOnePlus Real Time PCR system (Applied Biosystems) with a setting of 95˚C for 2 minutes and then 50 cycles of 95˚C for 30 seconds, 56˚C for 30 seconds, and 72˚C for 30 seconds. The level of the β-actin gene DNA was also determined for each DNA sample and used as an internal control for the qPCR assay. The level of the methylation-enriched target gene DNA in the untreated cells was counted as 100% and the level of the same target gene DNA in the treated cells was calculated as a fold change to that of the untreated cells for both NF and XPC cells. The qPCR data analysis was performed using a StepOne v2.1 software (Applied Biosystems).
Real Time PCR Assay
A reverse transcription-based quantitative PCR (real time PCR) assay was performed using a Sybr Green-based RNA quantification method (Applied Biosystems) [16] . The real time PCR was carried out in a StepOnePlus Real Time PCR system and analyzed by a StepOne v2.1 software to determine the relative levels of mRNA for the selected genes in each RNA sample. The level of the selected target gene mRNA in the untreated NF cells was counted as 100% and the levels of the same target mRNA in the other RNA samples were calculated as fold changes in comparison to that of the untreated NF cells.
ChIP Assay
The ChIP assay was performed using a previously described protocol [17] . The DNMT3A antibody (64B814) (Santa Cruz Biotechnologies, Inc., Santa Cruz, CA) was used in the ChIP study. Half of the beads obtained from the ChIP assay were analyzed by western blots to determine the level of DNMT3A protein pulling down by the antibody and the remaindering beads was processed to recover the DNA that was co-precipitated with the DNMT3A protein and analyzed by a qPCR protocol to OPEN ACCESS determine the DNA levels of desired target genes in each ChIP reaction.
Western Blot Hybridization
Western blots were performed using a previously described protocol [16] and 50 μg total protein was used in the western blots for each cell lysate. Antibodies against β-actin (C-2), DNMT1 (N-16), DNMT3A (64B814 and H-295), and DNMT3B (2280C3a), were purchased from the Santa Cruz Biotechnologies, Inc. and used in this study.
Statistical Analysis
Results were expressed as the mean ±S.D. Statistically significant differences were determined using a student t-test with 95% confidence interval (CI). The data was obtained from at least three independent experiments.
RESULTS
The XPC Deficiency Caused an Increase for TSC-Induced DNA Hypermethylation at the Promoter Region CpG Island-Containing Sequences of the Brca1, Mlh1, and Xpc
Genes in XPC Cells
In order to determine the role of XPC protein attenuation and deficiency in DNA hypermethylation of important tumor suppressor genes observed in many lung cancer patients, we first studied the effects of XPC protein deficiency on tobacco smoke-induced DNA hypermethylation in Brca1, Mlh1, and Xpc genes, which were frequently observed in lung cancer patients [21, [24] [25] [26] [27] [28] . Both NF (GM00043) and XPC (GM16684) cells were treated with TSC (25 μg/ml) for two months to allow for DNA hypermethylation accumulation in genomic DNA of the treated cells. As a control, the XPG cells, which are deficient in the XPG protein required for a late step of the NER process, were also treated with TSC in a parallel experiment; however, the XPG cells did not survive the two-month TSC treatment due to their high sensitivity to DNA-damaging treatment. Therefore, genomic DNA was prepared only from untreated and TSC-treated NF and XPC cells for our DNA methylation study. The genomic DNA was then digested with both BbvI and Dpn1 restriction enzymes to release the 372 bp, 390 bp, and 413 bp DNA fragments containing the promoter region CpG island sequences of the Brca1, Mlh1, and Xpc genes respectively. The methylated DNA fragments were enriched from the digested genomic DNA and quantified by a quantitative PCR (qPCR) protocol to determine the level of the promoter region CpG island-containing sequences of the Brca1, Mlh1, and Xpc genes in the methylation-enriched DNA samples ( Table 2 ). The results of our qPCR assay revealed that the TSC treatment caused some decrease in the level of DNA methylation for Brca1, Mlh1, and Xpc genes in NF cells ( The results of our DNA methylation studies suggested an important role of the XPC protein deficiency for TSC-induced DNA hypermethylation of the Brca1, Mlh1, and Xpc genes. To define a mechanism by which the XPC deficiency led to more elevated DNA hypermethylation of these genes in the TSC-treated XPC cells, we determined the protein levels of DNMT1, DNMT3A, and DNMT3B, three major DNA methyltransferases, in both untreated and TSC-treated NF and XPC cells (Figure 1) . The results of our western blots revealed that the protein levels of DNMT1, DNMT3A, and DNMT3B remained unchanged in both untreated and TSC-treated NF and XPC cells (Figure 1) , which suggests that increased expressions of individual DNMTs unlikely are the mechanism for TSC-induced DNA hypermethylation of the Brca1, Mlh1 and Xpc genes in the XPC cells.
To further elucidate a mechanism that led to the increased DNA hypermethylation of Brca1, Mlh1, and Xpc genes in the TSC-treated XPC cells, we investigated whether an increased binding of DNMT3A played a role in this process. We chose DNMT3A for this study because of its distinguished function to other DNMTs in DNA methylation: DNMT1 is a known maintenance DNA methyltransferase which is required for maintaining the DNA methylation pattern of the genome whereas DNMT3A and DNMT3B are de nova DNA methyltransferases which are required to set the DNA methylation pattern [29, 30] ; DNMT3B is expressed at very low levels in most tissues whereas the DNMT3A is broadly expressed in various tissues [31] . We performed a chromatin immunoprecipitation (ChIP) assay to determine the binding of DNMT3A at the promoter regions CpG island-containing sequences of the Brca1, Mlh1, and Xpc genes in both untreated and TSC-treated NF and XPC cells (Figure 2 and Table 3 ). The results of our western blots indicated that similar levels of DNMT3A protein were pulled down from all cell lysates in our ChIP studies (Figure 2(A) ), suggesting a very successful ChIP protocol. The results of our qPCR assay, however, revealed that different levels of target DNA sequences were pulled down from individual cell lysates: in NF cells the TSC treatment resulted in 0.76 ± 0.24, 1.60 ± 0.39, and 1.21 ± 0.26 fold change in DNA pulling down for the Brca1, Mlh1, and Xpc genes respectively in comparison to that of the untreated NF cells; in the XPC Figure 1 . The protein levels of DNMT1, DNMT3A, and DNMT3B in untreated and TSC-treated NF, XPG, and XPC cells. The cells were treated with TSC at the indicated concentration for 48 hours. Cell lysates (40 μg total protein) were analyzed by western blots to determine the protein levels of DNMT1, DNMT3A and DNMT3B in each cell lysate. The level of β-actin was also determined for each cell lysate and used as an internal control of protein loading. cells, the TSC treatment resulted in 1.62 ± 0.32, 6.95 ± 1.84, and 2.88 ± 0.53 fold change in DNA pulling down for the Brca1, Mlh1, and Xpc genes respectively in comparison to that of the untreated XPC cells (Figure 2(B) and Table 3 ). Interestingly, when the XPC cells were treated with 2 mM caffeine 24 hours prior to the TSC treatment, the TSC-induced DNMT3A binding at these sequences were partially diminished (Figure 2(B) and Table 3 ). These results indicated that the XPC deficiency caused an increase for TSC-induced DNMT3A binding at the promoter region CpG island-containing sequences of the Brca1, Mlh1, and Xpc genes in the XPC cells, suggesting that modulating DNMT3A's binding may play an important role for TSC-mediated DNA hypermethylation of the Brca1. Mlh1, and Xpc genes in the XPC cells.
The Involvement of ATR Protein for TSC-Induced DNMT3A Binding at the Promoter Region CpG Island-Containing Sequences of the Brca1, Mlh1, and Xpc Genes
The results of our ChIP studies revealed that the TSCinduced DNMT3A binding at the promoter region CpG island-containing sequence of the Mlh1 and Xpc genes was partially diminished when the XPC cells were treated with caffeine, which can inhibit the ATR kinase activity, prior to the TSC treatment, suggesting a possible role of ATR protein in the process. To further define the involvement of ATR protein in this process, we determined the protein-protein interaction between ATR and DNMT3A proteins in both untreated and TSC-treated NF and XPC cells using an immuno-precipitation (IP) protocol (Figure 3(A) ). When ATR protein was pulled down from individual cell lysates in our IP study, DNMT3A protein was also co-precipitated with the ATR protein from the cell lysates prepared from both untreated and TSC-treated NF and XPC cells (Figure 3(A) ), which suggests an interaction between the ATR and the DNMT3A protein. Interestingly, majority of the DNMT3A protein co-precipitated with the ATR protein in the IP study was from one of two DNMT3A protein bands as shown in the western blots (the lower band in Figure 3(A) ).
To further define the role of ATR protein in TSC-induced DNA hypermethylation of important target genes, we also determined the phosphorylation status of the ATR protein at serine 428, an indicator of ATR activation [32] [33] [34] [35] [36] , in both untreated and TSC-treated NF and XPC cells (Figure 3(B) ). Our western blot results indicated that the TSC treatment caused a greater increase in the level of the ATR phosphorylation at serine 428 in the XPC cells than that of the NF cells (Figure  3(B) top panel lane 4 vs lane 2) . This result suggests that activation of the ATR protein plays an important role for TSC-induced DNA hypermethylation of important target genes.
DISCUSSION
In this work we determined the role of XPC protein deficiency in tobacco smoke-caused DNA hypermethylation of the Brca1, Mlh1, and Xpc genes and further defined the involving mechanism. The results of our DNA methylation studies demonstrated that the XPC deficiency resulted in a greater increase for TSC-caused DNA methylation at the promoter region CpG island-containing sequences of the Brca1, Mlh1, and Xpc genes in XPC cells. The results of our ChIP studies revealed that the XPC deficiency caused a significant more increase for TSC-induced DNMT3A binding at the promoter region CpG island-containing sequences of the Brca1, Mlh1 and Xpc genes in XPC cells; however, this increase in DNMT3A binding was partially diminished when XPC cells were treated with caffeine prior to the TSC treatment. The results of our IP study further demonstrated that the ATR protein interacts with the DNMT3A. In addition, the results of our western blot studies also indicated that the XPC deficiency resulted in an increase for TSC-induced ATR phosphorylation at serine 428. Given the important roles of XPC and ATR proteins in DNA damage response (DDR) and the fact that attenuated levels of XPC protein are frequently observed in lung cancer patients, these results suggest that the XPC protein attenuation and deficiency play an important role for tobacco smoke-caused DNA hypermethylation of important tumor suppressor genes.
The results of our DNA methylation studies revealed that the XPC deficiency caused an increase for tobacco smoke-induced DNA hypermethylation of the Brca1, Mlh1, and Xpc genes in the XPC cells. Considering the important functions of the BRCA1 and MLH1 proteins in DNA repair and other DNA damage response, it is possible that silence of these genes is necessary for cells surviving the tobacco smoke-caused DNA damage; however, silence of these genes clearly could lead to some foreseeable consequence, such as uncontrolled cell proliferation and transformation from normal cells to tumor cells. Therefore, XPC protein attenuation and deficiency may lead to high risk of lung cancer development under tobacco smoking through enhancing tobacco smoke-induced DNA hypermethylation of important tumor suppressor genes and transformation from normal lung epithelial cells to lung tumor cells. In addition, although our studies only determined the DNA methylation status of the Brca1, Mlh1, and Xpc genes, it was likely that the DNA methylation status of many other tumor suppressors and cancer-related gene were also affected by XPC deficiency under the TSC exposure. Further identification of those genes, therefore, would provide a better understanding of the molecular mecha- nism of lung cancer development, especially for XPC protein attenuation and deficiency in tobacco smoke-caused lung cancer development.
The results of our ChIP studies revealed that the binding of DNMT3A at the promoter region CpG island-containing sequences of the Mlh1 and Xpc genes was significantly increased in the TSC-treated XPC cells. The underlying mechanism through which the XPC deficiency causes an increase in DNMT3A binding at these sequences in the TSC-treated XPC cells is unknown. The results of our studies, however, may suggest a possible mechanism. For example, the results of our western blot revealed that the XPC deficiency caused an increase for TSC-induced ATR phosphorylation at serine 435, an indicator of ATR activation (Figure 3(B) ). The results of our IP studies revealed that the ATR protein interacts with the DNMT3A protein (Figure 3(A) ). It is possible that the inability to initiate normal DNA damage response (e.g. DNA repair and cell cycle arrest) in the TSC-treated XPC cells causes an increase in replication and/or transcription stress, especially for those DNA damage responsive genes, and leads to recruitment and subsequently activation of ATR protein at these sequences [33, 37, 38] ; and the protein-protein interaction of DNMT3A with ATR helps recruit the DNMT3A to these sequences and the active ATR protein further modulates the DNMT3A protein either directly or indirectly, resulting in an increase in DNMT3A binding and hypermethylation of these sequences. Therefore, XPC deficiency may cause an increase in DNA hypermethylation of important tumor suppressor genes under the TSC exposure through activating the ATR signaling pathway. Further studies need to determine if the DNMT3A protein is modulated by ATR protein directly or indirectly and the sites within the DNMT3A protein that lead to modulation of the DNMT3A protein. In fact, work of others has already predicted some potential ATR modification sites within the DNMT3A protein although no work has been done in confirming the phosphorylation statuses of these sites (http://www.phosphonet.ca/Default.aspx?AspxAutoDete ctCookieSupport=1).
The mechanism through which DNMT3A protein selectively binds to particular target gene sequences is unknown. The work reported by Hervouet et al. indicates that the DNMT3A can be recruited to target gene sequences through specific transcription factors [39] . The work published by Le May et al. reveals that a functional XPC protein is required for demethylation of the promoter region CpG island sequences during gene transcription [40] . The results of our studies suggest that XPC deficiency leads to increased DNA hypermethylations of the Brca1, Mlh1, and Xpc genes following TSC treatment. It is possible that DNA damage caused DNA replication and/or transcription stress is essential to initiate the DNA hypermethylation process and XPC deficiency causes elevated DNA replication and/or transcription stress, resulting in an increase in DNA hypermethylation of important tumor suppressors and other cancer-related genes and development of lung cancer under tobacco smoking. Therefore, XPC deficiency and DNA hypermethylation of tumor suppressors and other cancer-related genes may provide a valuable biomarker in cancer prevention and treatment.
The method used in our DNA methylation study was the combination of methylated DNA enrichment and qPCR-based DNA quantification protocol, which provides a very accurate measurement to detect relative small changes in the level of DNA methylation for specific DNA sequences. This strategy can also be applied to other DNA sequencing technology, such as the sodium bisulfite-based Illumina Infinium Assay Technology (Il-lumina Inc., San Diego, CA), for determining global DNA methylation profiling, which would eventually lead to a better understanding of the mechanism of cancer development, especially for tobacco smoke-caused lung cancer development.
In conclusion, the results of our study provide direct evidence to suggest that the XPC protein attenuation and deficiency lead to more elevated levels of DNA hypermethylation of the Brca1, Mlh1, and XPC genes under the TSC treatment and this process requires the ATR and DNMT3A proteins. Therefore, the knowledge obtained from this study provides some valuable insight into the mechanism of lung cancer development, especially the role of XPC protein attenuation and deficiency in tobacco smoke-caused lung cancer development. This knowledge also will have important implications in detection, prevention, and treatment for many types of cancer in the future.
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